130 related articles for article (PubMed ID: 30268496)
1. S100A10 upregulation associates with poor prognosis in lung squamous cell carcinoma.
Sato K; Saiki Y; Arai K; Ishizawa K; Fukushige S; Aoki K; Abe J; Takahashi S; Sato I; Sakurada A; Okada Y; Horii A
Biochem Biophys Res Commun; 2018 Oct; 505(2):466-470. PubMed ID: 30268496
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Significance of S100A10 Expression in Lung Adenocarcinomas.
Katono K; Sato Y; Jiang SX; Kobayashi M; Saito K; Nagashio R; Ryuge S; Satoh Y; Saegusa M; Masuda N
Asian Pac J Cancer Prev; 2016; 17(1):289-94. PubMed ID: 26838226
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
4. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
5. Multiple functions of S100A10, an important cancer promoter.
Saiki Y; Horii A
Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
[TBL] [Abstract][Full Text] [Related]
6. DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism.
Yang X; Popescu NC; Zimonjic DB
Cancer Res; 2011 Apr; 71(8):2916-25. PubMed ID: 21372205
[TBL] [Abstract][Full Text] [Related]
7. Membranous overexpression of S100A10 is associated with a high-grade cellular status of breast carcinoma.
Arai K; Iwasaki T; Sonoda A; Endo A
Med Mol Morphol; 2020 Jun; 53(2):104-114. PubMed ID: 31728728
[TBL] [Abstract][Full Text] [Related]
8. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.
Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z
J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800
[TBL] [Abstract][Full Text] [Related]
9. S100A10, a novel biomarker in pancreatic ductal adenocarcinoma.
Bydoun M; Sterea A; Liptay H; Uzans A; Huang WY; Rodrigues GJ; Weaver ICG; Gu H; Waisman DM
Mol Oncol; 2018 Nov; 12(11):1895-1916. PubMed ID: 30009399
[TBL] [Abstract][Full Text] [Related]
10. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.
Madureira PA; Bharadwaj AG; Bydoun M; Garant K; O'Connell P; Lee P; Waisman DM
Oncotarget; 2016 Jul; 7(30):47720-47737. PubMed ID: 27351226
[TBL] [Abstract][Full Text] [Related]
11. S100A10 as a novel biomarker in colorectal cancer.
Shang J; Zhang Z; Song W; Zhou B; Zhang Y; Li G; Qiu S
Tumour Biol; 2013 Dec; 34(6):3785-90. PubMed ID: 23828264
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis.
Ito A; Koma Y; Uchino K; Okada T; Ohbayashi C; Tsubota N; Okada M
Cancer Lett; 2006 Mar; 234(2):239-48. PubMed ID: 15882926
[TBL] [Abstract][Full Text] [Related]
13. [Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer].
Chen XL; Zhang WG; Chen XY; Sun ZM; Liu SH
Ai Zheng; 2006 Sep; 25(9):1134-7. PubMed ID: 16965657
[TBL] [Abstract][Full Text] [Related]
14. Membranous S100A10 involvement in the tumor budding of colorectal cancer during oncogenesis: report of two cases with immunohistochemical analysis.
Arai K; Ishimatsu H; Iwasaki T; Tsuchiya C; Sonoda A; Ohata K
World J Surg Oncol; 2020 Nov; 18(1):289. PubMed ID: 33160379
[TBL] [Abstract][Full Text] [Related]
15. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
Bharadwaj AG; Kempster E; Waisman DM
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
[TBL] [Abstract][Full Text] [Related]
16. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
18. Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer.
Christensen MV; Høgdall C; Jensen SG; Lokman N; Ricciardelli C; Christensen IJ; Christiansen P; Brask J; Karlsen MA; Nissen TK; Jochumsen KM; Høgdall E
Anticancer Res; 2019 May; 39(5):2475-2482. PubMed ID: 31092442
[TBL] [Abstract][Full Text] [Related]
19. [Expression of glypican-3 in lung squamous cell carcinoma and adenocarcinoma and its relation with prognosis].
Li H; Deng Q; Huang L; Tang H; Cheng X
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):212-5. PubMed ID: 23443774
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of S100A10 in metastasized breast cancer stem cells.
Yanagi H; Watanabe T; Nishimura T; Hayashi T; Kono S; Tsuchida H; Hirata M; Kijima Y; Takao S; Okada S; Suzuki M; Imaizumi K; Kawada K; Minami H; Gotoh N; Shimono Y
Cancer Sci; 2020 Dec; 111(12):4359-4370. PubMed ID: 32976661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
